Your trusted destination for CME, CPD & Medical Education across the Middle East.
RAPID 2026: Recent Advances in Primary Immunodysregulation Disorders focuses on emerging developments in the diagnosis, evaluation, and management of primary immunodysregulation disorders. The event provides healthcare professionals with an opportunity to explore advances in immunology, genetics, targeted therapies, and multidisciplinary patient care.
RAPID 2026 brings together healthcare professionals and specialists to examine recent advances in primary immunodysregulation disorders and related immune-mediated conditions. The program explores contemporary approaches to clinical recognition, diagnostic evaluation, genetic investigation, and disease classification. Participants can gain insights into evolving treatment strategies, including targeted and immune-modulating therapies, as well as approaches to long-term patient management. The event also highlights the importance of early diagnosis and multidisciplinary collaboration in improving outcomes for patients with complex immune disorders. Through expert presentations and scientific discussion, RAPID 2026 supports knowledge exchange and continuing professional development in the field of clinical immunology.
Identifying classical warning signs and non-classical clinical clues of Inborn Errors of Immunity.
Exploring the latest advancements in laboratory diagnostics and functional testing for IEI.
Understanding the genetic basis of IEI from discovery to clinical diagnosis.
Translating molecular and genomic discoveries into actionable clinical insights.
Reviewing global and local guidelines for the management of Inborn Errors of Immunity.
Evaluating emerging therapeutics and the role of JAK inhibitors in PIRD targeted therapy.
Leveraging omics technologies, data science, and AI to enhance diagnostic pathways for precision care.
International experiences in whole genome newborn screening and pathways to clinical diagnosis.
State-of-the-art gene therapy for SCID and the successes and challenges of HSCT for IEI in children.
Advancing PID research through registry technology, including the USIDnet experience.
Insights from the Turkish, Kuwaiti, and MENAT IEI Research Consortium registries.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow